Breaking News

Financial Report: Johnson & Johnson 3Q11

Pharmaceutical sales up 9%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Johnson & Johnson 3Q11 3Q Revenues: $16.0 billion (+7%) 3Q Earnings: $3.2 billion (-6%) YTD Revenues: $48.8 billion (+6%) YTD Earnings: $9.5 billion (-17%) Comments: Worldwide Pharmaceutical sales were $6.0 billion in the quarter (+9%), but domestic sales were down 6%, impacted by generic competition for Levaquin. International sales increased 28%, which reflected an operational increase of 19% and a positive currency impact of 9%. Sales growth was attributed to recently launched produc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters